Tigran M. Abramyan

Tigran M. Abramyan

Auto-generated profile, based on publicly available information

Tigran M. Abramyan

Atomwise Inc., San Francisco, CA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2019 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
TATigran M. Abramyan
Tigran M. Abramyan
YAYi An
Yi An
Dmitri KireevDmitri Kireev
Dmitri Kireev

16 August 2017 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
ATAby Thyparambil
Aby Thyparambil
TATigran M. Abramyan
Tigran M. Abramyan
IBIngrid Bazin
Ingrid Bazin
Anthony Guiseppi-ElieAnthony Guiseppi-Elie
Anthony Guiseppi-Elie

22 August 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PAPercy S. Agogo-Mawuli
Percy S. Agogo-Mawuli
ISIsra Sadiya
Isra Sadiya
TATigran M. Abramyan
Tigran M. Abramyan
DBDustin Bosch
Dustin Bosch
Kyle A. EmmitteKyle A. Emmitte
Kyle A. Emmitte
DSDavid Peter Siderovski
David Peter Siderovski
Regulator of G protein Signaling-14 (RGS14), an intracellular inactivator of G protein-coupled receptor (GPCR) signaling, is considered an undruggable protein given its shallow and relatively featureless protein-protein interaction interface combined with a distal allosteric site prone to nonspecific inhibition by thiol-reactive compounds. Here, we identify and validate a tractable chemotype that selectively and non-covalently inhibits RGS14 GTPase-accelerating protein (GAP) activity. Combining structure-guided virtual screening, ligand docking across multiple receptor conformers, and enrichment validation, we progressed from a first-generation active, Z90276197, to over 40 second-generation analogs with improved potency. These inhibitors are predicted to engage the solvent-exposed "canyon" in the RGS14 RGS-box that interacts with the Gα switch I region. Binding pose predictions underscored the importance of non-polar interactions and shape complementarity over polar interactions in engaging this Gα-binding canyon and revealed an "ambidextrous" pattern of R1- and R2-group orientations. GAP inhibition was confirmed in fluorescence-based and gold-standard radioactive GTP hydrolysis assays. Two second-generation analogs, Z55660043 and Z55627844, inhibited RGS14 GAP activity in both assays and without measurable cytotoxicity. Deep learning-based scoring of predicted docking poses further supported observed affinity gains from R3-group additions. One analog demonstrated favorable in vivo pharmacokinetics and CNS penetration. Collectively, our findings establish tractable, non-covalent, small molecule inhibition of a G protein regulatory interface and illustrate how machine learning-enhanced docking can guide ligand optimization for shallow protein surfaces. This work opens the door to future development of RGS14 inhibitors as potential therapeutics for central nervous system and metabolic disorders.

24 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
AMArtur Meller
Artur Meller
SOSaulo de Oliveira
Saulo de Oliveira
Aram DavtyanAram Davtyan
Aram Davtyan
TATigran Abramyan
Tigran Abramyan
GBGregory R. Bowman
Gregory R. Bowman
HBHenry van Den Bedem
Henry van Den Bedem
Virtual screening is a widely used tool for drug discovery, but its predictive power can vary dramatically depending on how much structural data is available. In the best case, crystal structures of a ligand-bound protein can help find more potent ligands. However, virtual screens tend to be less predictive when only ligand-free crystal structures are available, and even less predictive if a homology model or other predicted structure must be used. Here, we explore the possibility that this situation can be improved by better accounting for protein dynamics, as simulations started from a single structure have a reasonable chance of sampling nearby structures that are more compatible with ligand binding. As a specific example, we consider the cancer drug target PPM1D/Wip1 phosphatase, a protein that lacks crystal structures. High-throughput screens have led to the discovery of several allosteric inhibitors of PPM1D, but their binding mode remains unknown. To enable further drug discovery efforts, we assessed the predictive power of an AlphaFold-predicted structure of PPM1D and a Markov state model (MSM) built from molecular dynamics simulations initiated from that structure. Our simulations reveal a cryptic pocket at the interface between two important structural elements, the flap and hinge regions. Using deep learning to predict the pose quality of each docked compound for the active site and cryptic pocket suggests that the inhibitors strongly prefer binding to the cryptic pocket, consistent with their allosteric effect. The predicted affinities for the dynamically uncovered cryptic pocket also recapitulate the relative potencies of the compounds (τ b =0.70) better than the predicted affinities for the static AlphaFold-predicted structure (τ b =0.42). Taken together, these results suggest that targeting the cryptic pocket is a good strategy for drugging PPM1D and, more generally, that conformations selected from simulation can improve virtual screening when limited structural data is available.

9 August 2024 in The Journal of Physical Chemistry C
Verified
Journal Article
Open access
SBSamuel Bearden
Samuel Bearden
TATigran M. Abramyan
Tigran M. Abramyan
DGDmitry Gil
Dmitry Gil
JJJessica Johnson
Jessica Johnson
AMAnton Murashko
Anton Murashko
GZGuigen Zhang
Guigen Zhang
The movement of small particles and molecules through nanopore membranes is widespread and has far-reaching implications. Consequently, the development of mathematical models is essential for understanding these processes on a micro level, leading to deeper insights. In this endeavor, we suggested a model based on a set of empirical equations to predict the transport of substances through a solid-state nanopore and the associated signals generated during their translocation. This model establishes analytical relationships between the ionic current and electrical double-layer potential observed during analyte translocation and their size, charge, and mobility in an electrolyte solution. This framework allows for rapid interpretation and prediction of the nanopore system's behavior and provides a means for quantitatively determining the physical properties of molecular analytes. To illustrate the analytical capability of this model, ceria nanoparticles were investigated while undergoing oxidation or reduction within an original nanopore device. The results obtained were found to be in good agreement with predictions from physicochemical methods. This developed approach and model possess transferable utility to various porous materials, thereby expediting research efforts in membrane characterization and the advancement of nano- and ultrafiltration or electrodialysis technologies.